_id

690db660ccc777a4e85d0e24

Ticker

BDSX

Name

Biodesix Inc

Exchange

NASDAQ

Address

919 West Dillon Road, Louisville, CO, United States, 80027

Country

USA

Sector

Healthcare

Industry

Diagnostics & Research

Currency

USD

Website

https://www.biodesix.com

Description

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Last Close

8.02

Volume

37432

Current Price

7.85

Change

-2.119700748129675

Last Updated

2025-11-28T12:47:58.687Z

Image

-

Ipo Date

2020-10-28T00:00:00.000Z

Market Cap

62960000

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9873333333333333

Sentiment Sources

3

Rating

4.5

Target Price

32.5

Strong Buy

4

Buy

1

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

21768000

Cost Of Revenue

4106000

Gross Profit

17662000

Operating Expenses

24713000

Operating Income

-7051000

Interest Expense

2073999

Pretax Income

-8716000

Net Income

-8716000

Eps

-1.1621333333333332

Dividends Per Share

-

Shares Outstanding

7955685

Income Tax Expense

-

EBITDA

-5235001

Operating Margin

-32.39158397647924

Total Other Income Expense Net

-1665000

Cash

16704000

Short Term Investments

-

Receivables

12674000

Inventories

1400000

Total Current Assets

33401000

Property Plant Equipment

30704000

Total Assets

88722000

Payables

3617000

Short Term Debt

1405000

Long Term Debt

47111000

Total Liabilities

90444000

Equity

-1722000

Depreciation

1378000

Change In Working Capital

-2943000

Cash From Operations

-8879000

Capital Expenditures

48000

Cash From Investing

-67000

Cash From Financing

4822000

Net Change In Cash

-4124000

PE

-

PB

-34.18989547038328

ROE

506.1556329849013

ROA

-9.823944455715607

FCF

-8927000

Fcf Percent

-0.4100973906651966

Piotroski FScore

0

Health Score

30

Deep Value Investing Score

1.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.8

Garp Investing Score

3

Growth Investing Score

3

Momentum Investing Score

2.5

Net Net Investing Score

1

Quality Investing Score

3

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

21768000

Quarters > 0 > income Statement > cost Of Revenue

4106000

Quarters > 0 > income Statement > gross Profit

17662000

Quarters > 0 > income Statement > operating Expenses

24713000

Quarters > 0 > income Statement > operating Income

-7051000

Quarters > 0 > income Statement > interest Expense

2073999

Quarters > 0 > income Statement > pretax Income

-8716000

Quarters > 0 > income Statement > net Income

-8716000

Quarters > 0 > income Statement > eps

-1.1621333333333332

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

7500000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-5235001

Quarters > 0 > income Statement > operating Margin

-32.39158397647924

Quarters > 0 > income Statement > total Other Income Expense Net

-1665000

Quarters > 0 > balance Sheet > cash

16704000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

12674000

Quarters > 0 > balance Sheet > inventories

1400000

Quarters > 0 > balance Sheet > total Current Assets

33401000

Quarters > 0 > balance Sheet > property Plant Equipment

30704000

Quarters > 0 > balance Sheet > total Assets

88722000

Quarters > 0 > balance Sheet > payables

3617000

Quarters > 0 > balance Sheet > short Term Debt

1405000

Quarters > 0 > balance Sheet > long Term Debt

47111000

Quarters > 0 > balance Sheet > total Liabilities

90444000

Quarters > 0 > balance Sheet > equity

-1722000

Quarters > 0 > cash Flow > net Income

-8716000

Quarters > 0 > cash Flow > depreciation

1378000

Quarters > 0 > cash Flow > change In Working Capital

-2943000

Quarters > 0 > cash Flow > cash From Operations

-8879000

Quarters > 0 > cash Flow > capital Expenditures

48000

Quarters > 0 > cash Flow > cash From Investing

-67000

Quarters > 0 > cash Flow > cash From Financing

4822000

Quarters > 0 > cash Flow > net Change In Cash

-4124000

Quarters > 0 > ratios > PE

-1.1621333333333332

Quarters > 0 > ratios > PB

-34.18989547038328

Quarters > 0 > ratios > ROE

506.1556329849013

Quarters > 0 > ratios > ROA

-9.823944455715607

Quarters > 0 > ratios > FCF

-8927000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-0.4100973906651966

Quarters > 0 > health Score

30

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

20018000

Quarters > 1 > income Statement > cost Of Revenue

4031000

Quarters > 1 > income Statement > gross Profit

15987000

Quarters > 1 > income Statement > operating Expenses

25706000

Quarters > 1 > income Statement > operating Income

-9719000

Quarters > 1 > income Statement > interest Expense

1898000

Quarters > 1 > income Statement > pretax Income

-11468000

Quarters > 1 > income Statement > net Income

-11468000

Quarters > 1 > income Statement > eps

-1.5639319223216235

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

7332800

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-8158000

Quarters > 1 > income Statement > operating Margin

-48.551303826556094

Quarters > 1 > income Statement > total Other Income Expense Net

-1749000

Quarters > 1 > balance Sheet > cash

20728000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

7451000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

32445000

Quarters > 1 > balance Sheet > property Plant Equipment

28241000

Quarters > 1 > balance Sheet > total Assets

87740000

Quarters > 1 > balance Sheet > payables

2973000

Quarters > 1 > balance Sheet > short Term Debt

1248000

Quarters > 1 > balance Sheet > long Term Debt

46782000

Quarters > 1 > balance Sheet > total Liabilities

86602000

Quarters > 1 > balance Sheet > equity

1138000

Quarters > 1 > cash Flow > net Income

-11468000

Quarters > 1 > cash Flow > depreciation

1436000

Quarters > 1 > cash Flow > change In Working Capital

2172000

Quarters > 1 > cash Flow > cash From Operations

-6568000

Quarters > 1 > cash Flow > capital Expenditures

51000

Quarters > 1 > cash Flow > cash From Investing

-95000

Quarters > 1 > cash Flow > cash From Financing

9789000

Quarters > 1 > cash Flow > net Change In Cash

3126000

Quarters > 1 > ratios > PE

-1.5639319223216235

Quarters > 1 > ratios > PB

50.582144112478026

Quarters > 1 > ratios > ROE

-1007.7328646748683

Quarters > 1 > ratios > ROA

-13.07043537725097

Quarters > 1 > ratios > FCF

-6619000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.33065241282845437

Quarters > 1 > health Score

9

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

17958000

Quarters > 2 > income Statement > cost Of Revenue

3703000

Quarters > 2 > income Statement > gross Profit

14255000

Quarters > 2 > income Statement > operating Expenses

23391000

Quarters > 2 > income Statement > operating Income

-9136000

Quarters > 2 > income Statement > interest Expense

1685000

Quarters > 2 > income Statement > pretax Income

-11101000

Quarters > 2 > income Statement > net Income

-11101000

Quarters > 2 > income Statement > eps

-1.5150088367554437

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

7327350

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-8011000

Quarters > 2 > income Statement > operating Margin

-50.874262167279205

Quarters > 2 > income Statement > total Other Income Expense Net

-1965000

Quarters > 2 > balance Sheet > cash

17603000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

7639000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

29622000

Quarters > 2 > balance Sheet > property Plant Equipment

28929000

Quarters > 2 > balance Sheet > total Assets

86241000

Quarters > 2 > balance Sheet > payables

2925000

Quarters > 2 > balance Sheet > short Term Debt

1112000

Quarters > 2 > balance Sheet > long Term Debt

36693000

Quarters > 2 > balance Sheet > total Liabilities

75181000

Quarters > 2 > balance Sheet > equity

11060000

Quarters > 2 > cash Flow > net Income

-11101000

Quarters > 2 > cash Flow > depreciation

1405000

Quarters > 2 > cash Flow > change In Working Capital

-739000

Quarters > 2 > cash Flow > cash From Operations

-8602000

Quarters > 2 > cash Flow > capital Expenditures

137000

Quarters > 2 > cash Flow > cash From Investing

-137000

Quarters > 2 > cash Flow > cash From Financing

97000

Quarters > 2 > cash Flow > net Change In Cash

-8642000

Quarters > 2 > ratios > PE

-1.5150088367554437

Quarters > 2 > ratios > PB

5.200695976491863

Quarters > 2 > ratios > ROE

-100.37070524412297

Quarters > 2 > ratios > ROA

-12.872067809974375

Quarters > 2 > ratios > FCF

-8739000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.4866354827931841

Quarters > 2 > health Score

12

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

20429000

Quarters > 3 > income Statement > cost Of Revenue

4342000

Quarters > 3 > income Statement > gross Profit

16087000

Quarters > 3 > income Statement > operating Expenses

22736000

Quarters > 3 > income Statement > operating Income

-6649000

Quarters > 3 > income Statement > interest Expense

1752000

Quarters > 3 > income Statement > pretax Income

-8251000

Quarters > 3 > income Statement > net Income

-8251000

Quarters > 3 > income Statement > eps

-1.1256249872103572

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

7330150

Quarters > 3 > income Statement > income Tax Expense

-1278724

Quarters > 3 > income Statement > EBITDA

-5101000

Quarters > 3 > income Statement > operating Margin

-32.546869646091345

Quarters > 3 > income Statement > total Other Income Expense Net

-1602000

Quarters > 3 > balance Sheet > cash

26245000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

8603000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

39484000

Quarters > 3 > balance Sheet > property Plant Equipment

29595000

Quarters > 3 > balance Sheet > total Assets

97244000

Quarters > 3 > balance Sheet > payables

2194000

Quarters > 3 > balance Sheet > short Term Debt

740000

Quarters > 3 > balance Sheet > long Term Debt

36408000

Quarters > 3 > balance Sheet > total Liabilities

76368000

Quarters > 3 > balance Sheet > equity

20876000

Quarters > 3 > cash Flow > net Income

-8251000

Quarters > 3 > cash Flow > depreciation

1398000

Quarters > 3 > cash Flow > change In Working Capital

658000

Quarters > 3 > cash Flow > cash From Operations

-4096000

Quarters > 3 > cash Flow > capital Expenditures

884000

Quarters > 3 > cash Flow > cash From Investing

-884000

Quarters > 3 > cash Flow > cash From Financing

-181000

Quarters > 3 > cash Flow > net Change In Cash

-5161000

Quarters > 3 > ratios > PE

-1.1256249872103572

Quarters > 3 > ratios > PB

2.7563555039279555

Quarters > 3 > ratios > ROE

-39.52385514466373

Quarters > 3 > ratios > ROA

-8.484842252478302

Quarters > 3 > ratios > FCF

-4980000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.24377110969699936

Quarters > 3 > health Score

17

Valuation > metrics > PE

-1.1621333333333332

Valuation > metrics > PB

-34.18989547038328

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

506.1556329849013

Profitability > metrics > ROA

-26.095027094997153

Profitability > metrics > Net Margin

-0.400404263138552

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-3.3997123431592784

Risk > final Score

16

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.650935882118678

Liquidity > metrics > Quick Ratio

6.372162485065711

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

27.99304023508137

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-14

Prev Risks > 1

-16

Prev Risks > 2

-9

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:16:11.587Z